Atlanta

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Liver and biliary tract cancer1 trial
• Ovarian cancer1 trial
• Prostate cancer1 trial
• Triple-negative breast cancer1 trial

Phase

• Phase 11 trial
• Phase 31 trial

Status

• Active, not recruiting1 trial
• Terminated1 trial

Lead sponsor

• Exelixis2 trials

Running trials

• Active, not recruiting

  Study of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Participants With Advanced Hepatocellular Carcinoma (HCC) Who Have Not Received Previous Systemic Anticancer Therapy

  NCT03755791· Phase 3· Exelixis· Source

Closed trials

• Terminated

  Study of XL102 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (QUARTZ-101)

  NCT04726332· Phase 1· Exelixis· Source